Ruxolitinib phosphate CAS:1092939-17-7

Details:

CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD. founded in 1984, engages in pharmaceutical research, development, production, process design and technical consultation of synthetic and fermentation pharmaceutical products. The organizational structure includes R&D Dept., Quality Inspection Dept., Pilot Plant and Sales Dept., etc.

Our pilot plant established 100,000 grade asepsis drug preparation workshop, biological extraction workshop as well as rectification, drying and packaging workshops for synthetic drug. Our laboratory has advanced inspection facilities such as UV, GC, HPLC etc. and equipped with high-pressure reactors, high vacuum and high fractional distillation.

Our products are exported to North American, European and Southeast Asian countries and the high quality of our products is positively recognized by our domestic and overseas clients.

CAS号:1092939-17-7  Ruxolitinibphosphate  phosphate;Ruxotinibphosphate;Jakafi(ruxolitinib);Ruxolitinib,Phosphate;INCB018424(phosphate);10-dimethoxyptercarpan;INCB018424(phosphateChemicalbook);INCB-018424(phosphate

Specification： 84-89°C   1.40    -20°  SolubleinDMSO(upto28mg/ml)orinEthanol(upto15mg/mlwithwarming).形态:Whitepowder.  (pKa):11.63±0.50(Predicted)   White 性:Stablefor1yearfromdateofpurchaseassupplied.SolutionsinDMSOorethanolmaybestoredat-20°foruptoChemicalbook3months.InChI:InChI=1/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/s3